Intensive blood-pressure control may delay cognitive impairment
Among 8,563 trial participants, intensive control reduced the relative rate of developing mild cognitive impairment versus the comparison group, with a hazard ratio of 0.67.

Our read
Interventions- Studied:
- Study of 8,563 SPRINT-MIND participants with adjudicated cognitive outcomes, against comparison group
- What changed:
- Mild cognitive impairment developed less often with intensive blood-pressure control versus the comparison group (hazard ratio 0.67)
- The catch:
- Blood-pressure targets are missing from the abstract, limiting guidance for care
- In the record:
- The 60th paper on intensive blood pressure control with results in people; 85 on record in all. Its result on mortality agrees with 13 of 15 other findings on record; 2 found no change.
Editor of record: Boris Djordjevic · AgingResearch.News
The 8,563 SPRINT-MIND participants with assessed cognitive outcomes were included in a secondary analysis of a blood-pressure control trial. Researchers modeled movement between normal cognition, two forms of mild cognitive impairment—a decline in thinking or memory—probable dementia, and death.
Intensive control appeared to act mainly before impairment began. The reduction was strongest for impairment not centered on memory. Intensive control did not reduce direct transitions from normal cognition to probable dementia. A possible reduction in progression from memory-related impairment to dementia was uncertain: the range of likely effects included no difference. The analysis estimated approximately 36 additional days alive with normal cognition over six years with intensive control versus the comparison group.
Why it matters
Preserving cognitive health with age involves both delaying impairment and limiting its progression. Separating those stages helps assess where blood-pressure control may contribute to dementia prevention.
Caveats
These findings came from a secondary analysis using models to estimate transitions between cognitive states and were reported in a conference abstract. The abstract does not give the blood-pressure targets, limiting how specifically the findings can guide care.
- Intensive blood pressure control
- Modeling and theory
- Mild cognitive impairment
- Probable dementia
- Amnestic mild cognitive impairment
- Humans
The paper
Rutgers, The State University of New Jersey; University of Virginia
AHA Scientific Sessions 2026 Abstract, Nov 2, 2026
Presented at AHA Scientific Sessions 2026, abstract 18659



Comments
Be the first to comment.